The companion diagnostics market report from The Business Research Company covers growth-driving insights such as companion diagnostics market size, companion diagnostics market trends and drivers, companion diagnostics market segmentation, companion diagnostics market competitive landscape and more

The companion diagnostics market is forecasted to achieve exponential growth in the coming few years with a forecast CAGR (compound annual growth rate) of more than 18%, as per The Business Research Company’s market report!

Read More On The Companion Diagnostics Market Report 2022 – https://www.thebusinessresearchcompany.com/report/companion-diagnostics-global-market-report

The Companion Diagnostics Market Size In 2022 And Forecast

The global companion diagnostics market is expected to grow from $4.37 billion in 2021 to $5.15 billion in 2022 at a compound annual growth rate (CAGR) of 17.86%. The global companion diagnostics market size is expected to reach $9.99 billion in 2026 at a compound annual growth rate (CAGR) of 18.01%.

The companion diagnostics market consists of sales of companion diagnostics solutions and services by entities (organizations, sole traders, and partnerships) that have an in vitro diagnostic medical device used to check the safety and effectivity of a corresponding drug or biological product.

Request for A Sample Of The Global Companion Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6078&type=smp

The Increasing Number Of Targeted Therapies Is Driving The Growth Of The Companion Diagnostics Market

According to the April 2021 article of the European Society for Medical Oncology, the genome-targeted therapy estimated eligibility was 8.82% by the end of 2018 and increased to 13.60% in 2020. Therefore, the rising number of therapies drives the companion diagnostics market.

Competitive Landscape And The Regional Analysis Of The Companion Diagnostics Market

Major players in the companion diagnostics market are F. Hoffmann-La Roche Ltd, Agilent Technologies Inc, Qiagen NV, Thermo Fisher Scientific Inc, Abbott Laboratories Inc, Myriad Genetics Inc, Almac Group, Illumina Inc, Seimens Healthineers AG, Abnova Corporation, Guardant Health Inc, ARUP Laboratories Inc, Foundation Medicine Inc, Bayer AG, Clinical Lab Products, Leica Biosystems Nussloch GmbH, and Life Technologies Tm.

Additionally, as per TBRC’s research – North America was the largest region in the companion diagnostics market in 2021 holding the largest market share.

The Companion Diagnostics Global Market Report 2022 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the companion diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the companion diagnostics market.

Technological Advancement – A Key Trend In The Companion Diagnostics Market

Artificial intelligence is used to develop more efficient drugs for companion diagnostics. The continuously gathered massive data sets from diverse genetic profiling have enabled the widespread application of AI.

Companion Diagnostics Market Segmentation By The Business Research Company

1) By Product and Service: Assays, Kits and Reagents, Software and Services

2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridization, Immunohistochemistry

3) By Indication: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma

4) By End-User: Pharmaceutical and Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations

Here Are Some Reports Related To The Companion Diagnostics Market –

Next Generation Sequencing Global Market Report 2022

Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Global Market Report 2022

Clinical Oncology Next Generation Sequencing Global Market Report 2022

Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found this article helpful? Share it on: